Valneva, a specialty vaccine maker, said a trial involving 4,000 participants in the U.K. prevented infections and severe disease as well as the vaccine from Oxford University and AstraZeneca, which was used as a comparison vaccine.
French drugmaker Valneva reports positive COVID-19 vaccine results
→
If the U.K. exercises all of its options, Valneva's deliveries would continue through 2025, the company said.
UK orders more Valneva vaccine to prepare for repeated jabs
→
